A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2011
11/09/2011	CN102239168A Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators
11/09/2011	CN102239164A 2h-chromene compound and derivative thereof
11/09/2011	CN102239159A 7-piperidinoalkyl-3,4-dihydroquinolone derivative
11/09/2011	CN102238954A D-tagatose-based compositions and methods for preventing and treating atherosclerosis, metabolic syndrome, and symptoms thereof
11/09/2011	CN102238947A Nutrient composition
11/09/2011	CN102234336A Fucoidan-galactosan sulfate, extracting, separating, and purifying method thereof, and application thereof
11/09/2011	CN102234331A Composition of Exendin-4 derivative and preparation method and application thereof
11/09/2011	CN102234303A Novel ecdysterone synthetic derivative and preparation method and application thereof
11/09/2011	CN102234281A Pyrimidine-fused cyclic derivative
11/09/2011	CN102234260A C-aryl glucoside derivatives containing difluoromethylene group
11/09/2011	CN102234231A 1-substituted-2-substituted-4- aryl substituted-butyl-2-alkene 1, 4-diketone compound, its preparation method and application
11/09/2011	CN102233101A Anti-hunger weight losing medicament
11/09/2011	CN102233100A Formula of medicinal preparation having health-care and treatment effects on deficiency of yin in lung and stomach and diabetic deficiency of yin
11/09/2011	CN102233098A Medicament for treating diabetes
11/09/2011	CN102233091A Nutritional and health-care Chinese medicine for treating liver diseases
11/09/2011	CN102233079A Defatting Chinese medicinal composition and preparation method thereof
11/09/2011	CN102233078A Use of medicinal composition in preparation of medicine for regulating and improving microenvironment of pancreas islet
11/09/2011	CN102233077A Use of medicinal composition in preparation of medicine for improving activity of adenosine 5'-monophosphate-activated protein kinase (AMPK)
11/09/2011	CN102233076A Application of pharmaceutical composition in preparing medicament for treating type 2 diabetes mellitus due to lipotoxicity by reducing SREBP1-C
11/09/2011	CN102233075A Use of medicinal composition in preparation of medicine for improving disorder of carbohydrate metabolism by regulating adenosine monophosphate -activated protein kinase (AMPK)-glucose transporter type 4(GLUT4)
11/09/2011	CN102233074A Application of medicine composition in preparing functional medicines for protecting islet belta cells
11/09/2011	CN102233067A Method for extracting cattail pollen total flavonoids by double aqueous phases
11/09/2011	CN102233056A Chinese medicine composition for treating diabetes and syndromes of diabetes
11/09/2011	CN102233049A Chinese medicine for curing diabetes
11/09/2011	CN102233018A Pawpaw leaven of carica papaya and rosaceae plants as well as preparation method and application thereof
11/09/2011	CN102232994A Method for preparing total phenols of Lignum Sappan
11/09/2011	CN102232990A Gynostemma pentaphylla blood tonifying nutrient solution and preparation method thereof
11/09/2011	CN102232967A Novel oral effervescent agent for calcium supply and preparation method thereof
11/09/2011	CN102232956A Compound for preventing and treating metabolic diseases and application thereof
11/09/2011	CN102232939A Novel mecobalamin sustained-release capsule and preparation method thereof
11/09/2011	CN102232936A Prescription and application of capsule for reducing hyperlipidemia model cholesterol
11/09/2011	CN102232553A Nutrient absorbing composition
11/09/2011	CN101912446B Application of forsythia chloroform extracts in preparing medicine for treating diabetes mellitus
11/09/2011	CN101904994B Chinese medicinal preparation for treating diabetes mellitus
11/09/2011	CN101869663B Chinese medicinal preparation for treating diabetes and preparation method thereof
11/09/2011	CN101810782B Medicament for treating diabetes
11/09/2011	CN101693062B Health-care product for reducing pressure and sugar and eliminating fat
11/09/2011	CN101637450B Levocarnitine liposomes injection and its preparation method
11/09/2011	CN101584719B Application of acanthopanax fruit extractive in preparing medicament for treating hyperlipoidemia
11/09/2011	CN101559181B Medicine for treating hyperlipidemia and preparation method thereof
11/09/2011	CN101549064B Medicament composition containing chilopod acting on NEI network and uses thereof
11/09/2011	CN101507710B Safe selenium-complement sustained-release microspheres and preparation method thereof
11/09/2011	CN101502621B Nutrient solution for cleaning blood and softening blood vessel
11/09/2011	CN101422450B Cajanus cajan L. natural medicine with blood sugar reduction and weight reduction function
11/09/2011	CN101411761B Novel use of plants in sorbus malus group of malus
11/09/2011	CN101411760B Novel use of plants in sorbus malus group of malus
11/09/2011	CN101269111B Method for extracting alpha-diastase restrainer from phaseolus limensis
11/09/2011	CN101253155B 11-beta-hydroxysteroid dehydrogenase-1-inhibitor-diabetes-type 2-1
11/09/2011	CN101244118B Method for preparing natural plants extract
11/09/2011	CN101229274B Pharmaceutical composition for preventing or treating impotence induced by hyperlipidemia and/or hypertension
11/09/2011	CN101176757B Pomegranate leaf extract preparations
11/09/2011	CN101112408B Sustained-release ji chrysanthemum tablet and method for preparing the same
11/09/2011	CN101048402B Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof
11/08/2011	US8053472 Quantity of acetyl L-carnitine to be administered is 0.1 to 2 g/day, while the dose of biotin is 1 to 8 mg/day
11/08/2011	US8053465 Bicycloester derivative
11/08/2011	US8053434 Kinase inhibitors and their uses
11/08/2011	US8053431 Pharmaceutical use of substituted amides
11/08/2011	US8053408 Methods for treating obesity using fibroblast growth factor-like polypeptides
11/08/2011	US8053206 Antagonists of HMG1 for treating inflammatory conditions
11/08/2011	US8052998 Mixture of biodegradable polymer and cationic polymer
11/08/2011	CA2665048C Crystalline forms of thiazolidinedione compound and its manufacturing method
11/08/2011	CA2653201C Compositions and uses of e3-gp19k for treating diabetes
11/08/2011	CA2526594C Use of tyrosine kinase inhibitors to treat diabetes
11/08/2011	CA2526208C Infusion preparation for peripheral parenteral administration and method for stabilizing vitamin b1
11/08/2011	CA2493436C Indolinone derivatives, substituted in the 6-position, their preparation and their use as medicaments
11/08/2011	CA2455655C A glycoprotein with antidiabetic, antihypertensive, antiobesity and antihyperlipidemic effects from grifola frondosa, and a method for preparing same
11/08/2011	CA2432185C Substituted pyridoindoles as serotonin agonists and antagonists
11/08/2011	CA2431675C Novel sulfamides and their use as endothelin receptor antagonists
11/08/2011	CA2247285C Human tumor necrosis factor delta and epsilon
11/05/2011	CA2738765A1 Biological environment for the preservation of a preparation of insulin secreting cells
11/03/2011	WO2011136573A2 Yeast hydrolysate having obesity treatment effects and antioxidant activity
11/03/2011	WO2011136469A2 Pharmaceutical composition using connective tissue growth factor
11/03/2011	WO2011136385A1 Bicyclic compound derivatives and their use as acc inhibitors.
11/03/2011	WO2011136378A1 Grafting material for genetic and cell therapy
11/03/2011	WO2011136269A1 Tetrahydrobenzothiophene compound
11/03/2011	WO2011135355A1 3-{ [5 -(azetidin-1-ylcarbonyl)pyrazin-2 -yl] oxy} -5-{ [(1s) -2 -hydroxy- 1 -methylethyl]oxy} -n- (5 -methylpyrazin-2-) benzamid monohydrate
11/03/2011	WO2011135276A1 3, 3 -disubstituted- ( 8 - aza - bicyclo [3.2.1] oct- 8 - yl) -[5- (1h - pyrazol - 4 -yl) -thiophen-3 -yl] methanones as inhibitors of 11 (beta) -hsd1
11/03/2011	WO2011135020A1 Use of a composition containing phospholipids and glycyrrhizinic acid for removing subcutaneous fat accumulations by means of subcutaneous lipolysis
11/03/2011	WO2011134284A1 Glucagon-like peptide-1 analogue and use thereof
11/03/2011	WO2011134280A1 Compounds as agonists of s1p1 receptors
11/03/2011	WO2011134191A1 Compound pharmaceutical formulation
11/03/2011	WO2011134063A1 Ccn3 and uses thereof against metabolic syndrome- associated disorders
11/03/2011	WO2011088055A3 Methionine aminopeptidase 2 (metap2) inhibitors for treating cardiovascular or cerebrovascular disorders
11/03/2011	WO2011062458A3 Composition containing homoisoflavanone as active ingredient for preventing and treating obesity or metabolic syndrome
11/03/2011	WO2011056037A3 Pharmaceutical composition containing, as active ingredients, lindera erythrocarpa extracts, fractions thereof, or compounds separated from the extracts
11/03/2011	WO2011052935A3 Composition for lowering blood sugar, comprising extract of smilax chine l., momordica charantia and cordyceps militaris as active ingredient
11/03/2011	WO2011049400A3 Pharmaceutical composition containing acid addition salt of n,n-dimethyl imidocarbonimidic diamide for anti-cancer
11/03/2011	WO2010134756A8 Composition comprising green tea extract
11/03/2011	WO2010116282A8 4, 5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
11/03/2011	US20110271358 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
11/03/2011	US20110270151 Image-guided energy deposition for targeted drug delivery
11/03/2011	US20110269842 Compositions comprising cb receptor agonists, uses thereof and methods for their preparation
11/03/2011	US20110269837 Phosphorus binder composition for treatment of hyperphosphatemia
11/03/2011	US20110269830 Statin nanoparticles
11/03/2011	US20110269828 Compositions and methods for treating and preventing weight-related disorders in companion animals
11/03/2011	US20110269817 Compositions and methods related to sirt1 function
11/03/2011	US20110269811 Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
11/03/2011	US20110269810 Selective inhibitors of c-jun n-terminal kinase
11/03/2011	US20110269802 Method of delivery of perishable liquid mixtures using mixing cap and container system
11/03/2011	US20110269795 Use of glucosidase inhibitors for therapy of mucovisidosis

1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 1298